7LBA Safety, activity, and response durability assessment of single agent rovalpituzumab tesirine, a delta-like protein 3 (DLL3)-targeted antibody drug conjugate (ADC), in small cell lung cancer (SCLC)
Conference Paper
Full Text
Duke Authors
Cited Authors
- Pietanza, MC; Spigel, D; Bauer, TM; Ready, NE; Glisson, BS; Morgensztern, D; Robert, F; Salgia, R; Kochendorfer, M; Patel, M; Strickland, DK; Govindan, R; Burris, HA; Rudin, CM; Dylla, S
Published Date
- September 2015
Published In
Volume / Issue
- 51 /
Start / End Page
- S712 - S712
Published By
International Standard Serial Number (ISSN)
- 0959-8049
Digital Object Identifier (DOI)
- 10.1016/s0959-8049(16)31931-1